CHLORTHALIDONE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for chlorthalidone and what is the scope of patent protection?
Chlorthalidone
is the generic ingredient in nine branded drugs marketed by Abbott, Ajanta Pharma Ltd, Alembic, Alkem Labs Ltd, Amneal Pharms Co, Ani Pharms, Appco, Ascot, Barr Labs Inc, Chartwell Rx, Cosette, Dava Pharms Inc, Inventia, Ivax Pharms, Kv Pharm, Mankind Pharma, Mutual Pharm, Mylan, Novast Labs, Pioneer Pharms, Purepac Pharm, Sandoz, Sun Pharm Industries, Sunny, Superpharm, Tagi, Umedica, Unichem, Usl Pharma, Vangard, Warner Chilcott, Watson Labs, Zydus Pharms, Sanofi Aventis Us, Casper Pharma Llc, Monarch Pharms, Par Pharm, Boehringer Ingelheim, and Novartis, and is included in sixty-eight NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-one drug master file entries for chlorthalidone. Thirty-four suppliers are listed for this compound.
Summary for CHLORTHALIDONE
US Patents: | 0 |
Tradenames: | 9 |
Applicants: | 39 |
NDAs: | 68 |
Drug Master File Entries: | 21 |
Finished Product Suppliers / Packagers: | 34 |
Raw Ingredient (Bulk) Api Vendors: | 106 |
Clinical Trials: | 66 |
Patent Applications: | 6,562 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for CHLORTHALIDONE |
Drug Sales Revenues: | Drug sales revenues for CHLORTHALIDONE |
What excipients (inactive ingredients) are in CHLORTHALIDONE? | CHLORTHALIDONE excipients list |
DailyMed Link: | CHLORTHALIDONE at DailyMed |
Recent Clinical Trials for CHLORTHALIDONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Insel Gruppe AG, University Hospital Bern | Phase 2 |
University of Bern | Phase 2 |
Jessa Hospital | Phase 4 |
Pharmacology for CHLORTHALIDONE
Drug Class | Thiazide-like Diuretic |
Physiological Effect | Increased Diuresis |
Medical Subject Heading (MeSH) Categories for CHLORTHALIDONE
US Patents and Regulatory Information for CHLORTHALIDONE
Expired US Patents for CHLORTHALIDONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Casper Pharma Llc | THALITONE | chlorthalidone | TABLET;ORAL | 019574-001 | Dec 20, 1988 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.